Genetix Biotech Asia Limited, a active public limited company, was established on 10 October 2001 in Delhi, Delhi, India. Engaging in medical & laboratory equipment within the trade sector, it holds CIN: U24239DL2001PLC112768. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹10.65 Cr.
It upholds a compliant status. Employing 127 professional, Its leadership includes Arun Prakash (Managing Director), Raminder Kaur (Whole-Time Director), Navin Chandra Khanna (Director). Past directors included Arun Prakash, Raminder Kaur, Kailash Parkash. It holds ₹118.69 Cr open charges and ₹64.30 Cr settled loans. Its latest AGM occurred on 30 December 2024, with the balance sheet filed on 31 March 2024. It is based at House No.71/1, First Floor, Shivaji Marg, Najafgarh Road, Delhi, Delhi, 110015.
U24239DL2001PLC112768
112768
10 October 2001
₹15.00 Cr
₹10.65 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Genetix Biotech Asia Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arun Prakash | Managing Director | 10 Oct 2001 | Current |
| Raminder Kaur | Whole-Time Director | 10 Oct 2001 | Current |
| Navin Chandra Khanna | Director | 08 Feb 2025 | Current |
| Samuel John Farrimond | Director | 11 Dec 2024 | Current |
| Rakesh Kumar Dubey | Director | 18 Nov 2024 | Current |
| Poonam Deep | Director | 16 May 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Sep 2024 | Past |
| Pramod Abcsdd | Director | 05 Sep 2024 | Past |
| Pramod Abcsdd | Director | 05 Oct 2018 | Past |
| Pramod Abcsdd | Additional Director | 28 Dec 2024 | Past |
| Pramod Abcsdd | Additional Director | 18 Mar 2025 | Past |
| Pramod Abcsdd | Additional Director | 29 Dec 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Genetix Biotech Asia Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 53.23% decrease. The company also saw a substantial fall in profitability, with a 74.3% decrease in profit. The company's net worth Soared by an impressive increase of 10.3%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Genetix Biotech Asia had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,186,921,201.00
₹642,950,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Sep 2025 | Others | ₹25.00 Cr | Open |
| 10 Aug 2024 | Others | ₹8.00 M | Open |
| 24 Jan 2024 | Others | ₹11.06 Cr | Open |
| 04 Jan 2024 | Hdfc Bank Limited | ₹0.46 M | Open |
| 18 Jan 2023 | Hdfc Bank Limited | ₹1.21 M | Open |
Explore comprehensive loan charge details -
Genetix Biotech Asia has a workforce of 127 employees as of Jan 13, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Genetix Biotech Asia, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genetix Biotech Asia's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 25.00 Cr with Charge ID 101178681 was registered on 26 Sep 2025. was recorded as a recent event.
Navin Chandra Khanna was appointed as a Director was appointed as a Director on 08 Feb 2025 & has been associated with this company since 9 months 20 days . was recorded as a recent event.
The activity Genetix Biotech Asia Limited last Annual general meeting of members was held on 30 Dec 2024 as per latest MCA records. was completed.
Progress on Samuel John Farrimond was appointed as a Director was appointed as a Director on 11 Dec 2024 & has been associated with this company since 11 months 18 days . was documented.
Rakesh Kumar Dubey was appointed as a Director was appointed as a Director on 18 Nov 2024 & has been associated with this company since 1 year 10 days . was recorded as a recent event.
A charge with Citi Bank N.A. of Rs. 25.00 Cr registered on 18 Aug 2020 with Charge ID 100360156 was modified on 06 Nov 2024. was recorded as a recent event.
The CIN of Genetix Biotech Asia Limited is U24239DL2001PLC112768.
Genetix Biotech Asia Limited is headquartered at House No.71/1, First Floor, Shivaji Marg, Najafgarh Road, Delhi, Delhi, 110015.
Genetix Biotech Asia Limited was incorporated on 10 October 2001.
The current directors of Genetix Biotech Asia Limited are
The primary industry of Genetix Biotech Asia Limited is Trade.
Genetix Biotech Asia Limited is unlisted.
The authorized capital of Genetix Biotech Asia Limited is ₹15.00 Cr, and the paid-up capital is ₹10.65 Cr.
The compliance status of Genetix Biotech Asia Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX